BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Muthyala A, Sasidharan S, John KJ, Lal A, Mishra AK. Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2. World J Virol 2022; 11(5): 375-390 [PMID: 36188743 DOI: 10.5501/wjv.v11.i5.375]
URL: https://www.wjgnet.com/2220-3249/full/v11/i5/375.htm
Number Citing Articles
1
Ali Osman Gulmez, Sonay Aydin. Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2World Journal of Virology 2023; 12(2): 132-135 doi: 10.5501/wjv.v12.i2.132
2
Aysegul Kirankaya, Levent Deniz, Sevil Tugrul, Sevgi Ozcan, Suat Hayri Kucuk, Zeynep Atam Tasdemir, Ertugrul Okuyan, Irfan Sahin. Investigation of the relationship between vascular events and copeptin levels in hospitalized COVID-19 patientsTurkish Journal of Biochemistry 2025; 50(4): 537 doi: 10.1515/tjb-2024-0242
3
Arti Srivastava, Shankar Nalroad Sundararaj, Jagriti Bhatia, Dharamvir Singh Arya. Understanding long COVID myocarditis: A comprehensive reviewCytokine 2024; 178: 156584 doi: 10.1016/j.cyto.2024.156584
4
Harinivaas Shanmugavel Geetha, Sushmita Prabhu, Abinesh Sekar, Maya Gogtay, Yuvaraj Singh, Ajay K Mishra, George M Abraham, Suzanne Martin. Use of inflammatory markers as predictor for mechanical ventilation in COVID-19 patients with stages IIIb-V chronic kidney disease?World Journal of Virology 2023; 12(5): 286-295 doi: 10.5501/wjv.v12.i5.286
5
Hari P. Sritharan, Kunwardeep S. Bhatia, William van Gaal, Leonard Kritharides, Clara K. Chow, Ravinay Bhindi. Association between pre-existing cardiovascular disease, mortality and cardiovascular outcomes in hospitalised patients with COVID-19Frontiers in Cardiovascular Medicine 2023; 10 doi: 10.3389/fcvm.2023.1224886